Epilepsy, Generalized: Clinical Trials

236 trials for Epilepsy, Generalized, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

112 completed, 28 recruiting, 28 terminated, 20 unknown. 70 Phase 3, 51 Phase 2, 30 Not applicable, 23 Phase 1, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 370Completed 35, Terminated 11, Unknown 7, Recruiting 5, Withdrawn 5, Active not recruiting 4, Enrolling by invitation 2, Suspended 1
Phase 251Completed 16, Terminated 12, Recruiting 8, Active not recruiting 6, Unknown 6, Withdrawn 2, Not yet recruiting 1
Not applicable30Completed 15, Terminated 4, Recruiting 3, Unknown 3, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 123Completed 11, Active not recruiting 5, Recruiting 3, Terminated 2, Not yet recruiting 1, Unknown 1
Phase 413Completed 6, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Withdrawn 1
Early Phase 11Recruiting 1

Follow Epilepsy, Generalized: new trials by email Literature Review of Epilepsy, Generalized trials Research Report on Epilepsy, Generalized

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years
Intervention 1, Intervention 2 - Idiopathic Generalized Epilepsy
Not applicableNot yet recruitingOregon Health and Science University102027-02-012026-09-04
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
Phase 4Not yet recruitingElizabeth Donner252027-01-012026-09-11
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
Glycerol Phenylbutyrate - SLC6A1
Phase 2RecruitingScripps Translational Science Institute202026-10-012026-09-29
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
JZP926 capsule, Placebo - Juvenile Myoclonic Epilepsy
Phase 2 / Phase 3RecruitingJazz Pharmaceuticals2602026-09-182026-10-06
Biomarkers of Neurodegeneration, Synaptic Plasticity and Neuroinflammation in Dravet Syndrome
Dravet Syndrome (DS)
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS902026-09-152026-09-03
IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).
Monitoring of patients using electroencephalogram, a Bispectral Index (BIS) and Sedline monitors. - Epileptic Encephalopathy, Early Infantile Epileptic Encephalopathy
Not yet recruitingTelethon Kids Institute402026-09-032026-07-17
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
ION337 - Dravet Syndrome
Phase 1 / Phase 2RecruitingIonis Pharmaceuticals, Inc.322026-05-212026-09-03
A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
[18F]MPPF PET-MRI - Epilepsy, Dravet Syndrome
Not applicableRecruitingHospices Civils de Lyon302026-05-042026-05-08
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) - Dravet Syndrome
Phase 4RecruitingThe University of Texas Health Science Center, Houston252026-04-272026-07-15
Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS
Byteflies Remote patient monitoring solution (with reduced EEG) - Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS)
Not applicableEnrolling by invitationByteflies202026-04-202026-10-08
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Levetiracetam 500mg, Placebo - Down Syndrome, Down Syndrome (DS)
Phase 3RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1202025-12-222026-01-12
A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
RC001 injection-Dose Escalation Cohort, RC001 injection-Fixed Dose Cohort - Dravet Syndrome (DS)
Early Phase 1RecruitingSecond Affiliated Hospital of Guangzhou Medical University82025-12-222026-06-30
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
Epilepsy, West Syndrome
RecruitingAssistance Publique - Hôpitaux de Paris10002025-12-112026-02-24
Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation
nL-ATN1-001 - Dentatorubral-Pallidoluysian Atrophy
Phase 1 / Phase 2Active not recruitingn-Lorem Foundation12025-11-062026-04-07
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
vormatrogine - Epilepsy, Tonic-Clonic, Focal Seizure
Phase 3Enrolling by invitationPraxis Precision Medicines7002025-10-272026-08-03
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Dravet Syndrome
RecruitingAssistance Publique - Hôpitaux de Paris502025-09-152026-02-03
Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
Ketogenic diet - Developmental and Epileptic Encephalopathies, Epileptic Spasms
Phase 1TerminatedHeather Olson12025-08-112026-10-14
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
Target optimization using LIFU, Serial LIFU stimulation - Drug-Resistant Epilepsy, Epilepsy
Not applicableRecruitingUniversity of California, San Francisco402025-07-092026-07-02
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
zorevunersen, Sham Comparator - Dravet Syndrome
Phase 3Active not recruitingStoke Therapeutics, Inc1702025-06-042026-10-20
Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)
Stiripentol capsule (Diacomit®), Stiripentol oral suspension (Diacomit®) - Dravet Syndrome, Epilepsy
Phase 1CompletedBiocodex242025-06-012025-09-16

Showing 20 of 236. Sign in to see all of them.

Narrower conditions

Epilepsies, Myoclonic (92)  ·  Epilepsy (82)  ·  Seizures (62)  ·  Spasms, Infantile (47)  ·  Lennox Gastaut Syndrome (30)  ·  Epilepsy, Absence (24)  ·  Epilepsy, Tonic-Clonic (23)  ·  Epilepsies, Partial (13)  ·  Drug Resistant Epilepsy (11)  ·  Myoclonic Epilepsies, Progressive (11)  ·  Epilepsy, Idiopathic Generalized (9)  ·  Tuberous Sclerosis (8)  ·  Brain Diseases (6)  ·  CDKL5 deficiency disorder (6)

Broader conditions

Central Nervous System Diseases (234)  ·  Nervous System Diseases (234)  ·  Brain Diseases (230)  ·  Epileptic Syndromes (181)  ·  Epilepsy (154)  ·  Pathological Conditions, Signs and Symptoms (91)  ·  Neurologic Manifestations (81)  ·  Signs and Symptoms (81)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (53)  ·  Genetic Diseases, Inborn (52)  ·  Neurodegenerative Diseases (25)  ·  Epilepsies, Myoclonic (24)  ·  Heredodegenerative Disorders, Nervous System (22)  ·  Pathologic Processes (21)

Interventions

Cannabidiol (21)  ·  Fenfluramine (14)  ·  Levetiracetam (9)  ·  Topiramate (7)  ·  Vigabatrin (7)  ·  Prednisolone (5)  ·  brivaracetam (5)  ·  stiripentol (5)  ·  Clobazam (4)  ·  Lamotrigine (4)  ·  Valproic Acid (4)  ·  soticlestat (4)  ·  Adrenocorticotropic Hormone (3)  ·  Diet, Ketogenic (3)  ·  Pyridoxine (3)

Sponsors

Jazz Pharmaceuticals (10)  ·  Takeda (7)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6)  ·  University of Colorado, Denver (6)  ·  Lady Hardinge Medical College (5)  ·  Longboard Pharmaceuticals (5)  ·  UCB Pharma (5)  ·  Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (5)  ·  Encoded Therapeutics (4)  ·  Lundbeck LLC (4)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  All India Institute of Medical Sciences (3)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)  ·  Gillette Children's Specialty Healthcare (3)

Countries

United States (133)  ·  France (34)  ·  Italy (31)  ·  Spain (28)  ·  Canada (25)  ·  United Kingdom (23)  ·  Australia (22)  ·  Germany (22)  ·  Poland (16)  ·  Belgium (15)  ·  India (14)  ·  Netherlands (13)  ·  Japan (11)  ·  China (10)  ·  Brazil (9)

Top investigators

Neha Parikh (3)  ·  Salvador Rico, M.D., Ph.D (3)  ·  Ahmed Elkashef, MD (2)  ·  Alexander Rotenberg, MD, PhD (2)  ·  Ann Dandurand, MD (2)  ·  Beverly S Wical, MD (2)  ·  Dennis J Dlugos, MD (2)  ·  Domenica Immacolata Battaglia (2)

Results publications

PMID 34768178, PMID 17283312, PMID 19327967, PMID 26666500, PMID 33461041, PMID 33540241, PMID 34265088, PMID 41780062, PMID 10208286, PMID 10227614, PMID 10368073, PMID 10561962, PMID 10565592, PMID 10768306, PMID 11117539, PMID 11673582, PMID 11976067, PMID 12403260, PMID 12690085, PMID 14734931, PMID 15069466, PMID 15145300, PMID 15159460, PMID 15509243, PMID 15521903, PMID 15541450, PMID 15794175, PMID 16344515, PMID 16406488, PMID 16524783, PMID 17625106, PMID 17826314, PMID 18077226, PMID 18285535, PMID 1947597, PMID 19682955, PMID 20200383, PMID 20608959, PMID 20685215, PMID 20937567, PMID 21070215, PMID 21352847, PMID 21454134, PMID 21920781, PMID 21956725, PMID 22050371, PMID 22378657, PMID 22658946, PMID 22689735, PMID 22859699

NIH funding

2023 (5), 2014 (4), 2015 (2), 2016 (2), 2018 (2), U54NS078059 (2), 2004 (1), 2017 (1), 2019 (1), K12TR004410 (1), R01HD102723 (1), R01NS037466 (1), R43NS129363 (1), RC3NS070658 (1), U01NS045803 (1)